雷火电竞app

EN
EN
ABOUT US
Our History
ABOUT US
Our History
2024
2023
2022
2021
2020
2019
2018
2017
2015
2014
2012
2011
2010
2024
InnoAlliance Founded in San Francisco, U.S.A. InnoStar was listed on the STAR Market of Shanghai Stock Exchange (Stock code: 688710).
2024
2023
InnoStar’s headquarters and innovation transformation center construction project started in Shanghai International Medical Zone InnoStar Shenzhen successfully passed the NMPA GLP certification for the first time InnoStar Shenzhen successfully received the AAALAC certification for the first time Shanghai headquarters received the AAALAC certification for the fifth time
2023
2022
Nantong InnoStar's expanded laboratory and office buildings were put into operation. Shanghai headquarters passed the periodical GLP inspection by Shanghai authorities. Shanghai headquarters received the CAP certification for the fourth time. Shanghai headquarters successfully passed the clinical sample analysis experiment (BE) inspection.
2022
2021
Huangshan InnoStar Bio-tech Co., Ltd. was established. Nantong InnoStar received the NMPA GLP certification for additional studies. Huangshan InnoStar received the license of domestication and breeding of wild animals under national priority-protection.
2021
2020
Shenzhen InnoStar Biomedical Safety Evaluation and Research Institute Co., Ltd. was established. Nantong InnoStar received the NMPA GLP certification for the first time.
2020
2019
Shanghai headquarters received the OECD GLP certification (Netherlands) for the fourth time. Shanghai headquarters passed the NMPA GLP inspection for the fourth time. Nantong InnoStar received the AAALAC certification for the first time.
2019
2018
Nantong InnoStar Bio-tech Co., Ltd. was constructed and put into operation. Shanghai headquarters passed the inspection by the U.S Food and Drug Administration (FDA) for the second time.
2018
2017
After the shareholding system reform, Shanghai lnnoStar Bio-tech Co., LTD was formally established. Shanghai headquarters received the AAALAC certification for the second time. Shanghai headquarters received the OECD GLP certification (Netherlands) for the third time. Shanghai lnnoStar received the CAP certification after re-inspection.
2017
2015
Shanghai headquarters received the certification from the College of American Pathologists (CAP) for the first time. Shanghai headquarters received the NMPA GLP certification for the second time. Shanghai headquarters received the OECD GLP certification (Netherlands) for the second time.
2015
2014
Pharmaceutical Metabolism Research Division was founded. Shanghai headquarters passed the inspection by the U.S FDA for the first time.
2014
2012
Shanghai headquarters received the OECD GLP certification (Netherlands) for the first time.
2012
2011
Shanghai headquarters received the NMPA GLP certification for the first time. Shanghai headquarters received the AAALAC certification for the first time.
2011
2010
Shanghai InnoStar Bio-tech Co., Ltd. was established.
2010
Copyright © 2017-2021©Shanghai InnoStar Bio-tech Co., Ltd. All Rights Reserved. Created By VPABrand.com